BIOEX Stock Overview
Develops and commercializes a bio-based extraction platform technology. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Bioextrax AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 2.86 |
| 52 Week High | SEK 4.50 |
| 52 Week Low | SEK 1.54 |
| Beta | 2.65 |
| 1 Month Change | -20.11% |
| 3 Month Change | -16.86% |
| 1 Year Change | -8.77% |
| 3 Year Change | -95.17% |
| 5 Year Change | n/a |
| Change since IPO | -28.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| BIOEX | SE Machinery | SE Market | |
|---|---|---|---|
| 7D | -12.8% | 1.6% | -0.8% |
| 1Y | -8.8% | 6.1% | 6.6% |
Return vs Industry: BIOEX underperformed the Swedish Machinery industry which returned 6.1% over the past year.
Return vs Market: BIOEX underperformed the Swedish Market which returned 6.6% over the past year.
Price Volatility
| BIOEX volatility | |
|---|---|
| BIOEX Average Weekly Movement | 7.7% |
| Machinery Industry Average Movement | 4.1% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.6% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: BIOEX has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: BIOEX's weekly volatility has decreased from 13% to 8% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 13 | Edvard Hall | www.bioextrax.com |
Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. It harvests bioplastics (PHA) granules, organic hydrolyzed protein, keratin fibers, bio-oils, protein-rich by products, and amino acids from bacteria. The company was incorporated in 2014 and is based in Lund, Sweden.
Bioextrax AB (publ) Fundamentals Summary
| BIOEX fundamental statistics | |
|---|---|
| Market cap | SEK 100.29m |
| Earnings (TTM) | -SEK 19.64m |
| Revenue (TTM) | SEK 1.57m |
63.9x
P/S Ratio-5.1x
P/E RatioIs BIOEX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIOEX income statement (TTM) | |
|---|---|
| Revenue | SEK 1.57m |
| Cost of Revenue | SEK 1.46m |
| Gross Profit | SEK 114.00k |
| Other Expenses | SEK 19.76m |
| Earnings | -SEK 19.64m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.56 |
| Gross Margin | 7.26% |
| Net Profit Margin | -1,251.27% |
| Debt/Equity Ratio | 0% |
How did BIOEX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/11 19:16 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bioextrax AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|